OVID · Forms 3, 4, 5
Insider trades at Ovid Therapeutics Inc.
No open-market insider buys or sells at Ovid Therapeutics Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Ovid Therapeutics Inc. (OVID) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Ovid Therapeutics Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Charles Ross Carter | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Charles Ross Carter | Chief Financial Officer | Award | 50,000 | Form 4 | |||
| Anna Greka | Director | Options or other derivatives | Form 4 | ||||
| Anna Greka | Director | Became an insider (Form 3) | Form 3 | ||||
| Stelios Papadopoulos | Director | Award | 17,578 | $2.56 | $45K | Form 4 | |
| Bart Friedman | Director | Award | 8,789 | $2.56 | $22K | Form 4 | |
| Kevin Joseph Fitzgerald | Director | Award | 17,578 | $2.56 | $45K | Form 4 | |
| Jeremy M Levin | Executive Chairman | Option exercise | 47,333 | $1.40 | $66K | Form 4 | |
| Stelios Papadopoulos | Director | Options or other derivatives | Form 4 | ||||
| Margaret A. Alexander | President and CEO | Sell | 11,656 | $1.45 | $17K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.